are compounded semaglutide being discontinued (GLP-1) FDA issues warning about some

Adults and children 12 years of age and older may take 1 tablespoon at a time of this fiber powder, up to three times daily, and children ages 6 to 11 years may take 2 level teaspoons up to three times daily

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time

On the flipside, there are challenges: for example, concerns about cost to healthcare systems and equity of access for patients with the greatest unmet needs, or the possible impact on Medtech currently used by patients suffering from obesity related conditions for example knee replacements for overweight patients with eroded joints or CPAP machines for sleep apnoea, a complication of obesity

Ready to achieve your goals